Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings

Rheumatology International

Volumn 32, Issue 2, 2012, Pages 387-393

  Andersen, Thomas ^a   Rasmussen, Tue Kruse ^a   Hvid, Malene ^a,b   Holm, Christian Kanstrup ^a   Madsen, Karen Jong Nyo Berenth ^b   Jurik, Anne Grethe ^b   Hokland, Marianne ^a   Stengaard Pedersen, Kristian ^b   Schiøttz Christensen, Berit ^c   Deleuran, Bent ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Aarhus Clinic for Rheumatic Diseases   (Denmark)

Author keywords

IL 17; IL 21; IL 23; Inflammation; MRI; Spondyloarthropathy

Indexed keywords

C REACTIVE PROTEIN; CD45RO ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCORING SYSTEM; SYNOVIAL FLUID; TH17 CELL;

ADULT; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKINS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SPONDYLITIS, ANKYLOSING; UP-REGULATION;

EID: 84857051543     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1655-3     Document Type: Article

References (24)

1. S van der Linden HA Valkenburg A Cats 1984 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27 361 368 6231933 10.1002/art.1780270401 (Pubitemid 14134775)
2. PR Burton DG Clayton LR Cardon N Craddock P Deloukas A Duncanson DP Kwiatkowski MI McCarthy, et al. 2007 Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants Nat Genet 39 1329 1337 17952073 10.1038/ng.2007.17 1:CAS:528:DC%2BD2sXht1aqtrvF (Pubitemid 350041542)
3. G Layh-Schmitt RA Colbert 2008 The interleukin-23/interleukin-17 axis in spondyloarthritis Curr Opin Rheumatol 20 392 397 18525350 10.1097/BOR. 0b013e328303204b 1:CAS:528:DC%2BD1cXms1yntL0%3D
4. NJ Wilson K Boniface JR Chan BS McKenzie WM Blumenschein JD Mattson B Basham K Smith, et al. 2007 Development, cytokine profile and function of human interleukin 17-producing helper T cells Nat Immunol 8 950 957 17676044 10.1038/ni1497 1:CAS:528:DC%2BD2sXptlSku7o%3D (Pubitemid 47300009)
5. S Aggarwal N Ghilardi MH Xie FJ de Sauvage AL Gurney 2003 Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 J Biol Chem 278 1910 1914 12417590 10.1074/jbc.M207577200 1:CAS:528:DC%2BD3sXisFyksA%3D%3D (Pubitemid 36801431)
6. L Yang DE Anderson C Baecher-Allan WD Hastings E Bettelli M Oukka VK Kuchroo DA Hafler 2008 IL-21 and TGF-beta are required for differentiation of human T(H)17 cells Nature 454 350 352 18469800 10.1038/nature07021 1:CAS:528:DC%2BD1cXosFCqs7o%3D
7. WJ Leonard R Zeng R Spolski 2008 Interleukin 21: a cytokine/cytokine receptor system that has come of age J Leukoc Biol 84 348 356 18467657 10.1189/jlb.0308149 1:CAS:528:DC%2BD1cXptF2htr0%3D
8. J Parrish-Novak SR Dillon A Nelson A Hammond C Sprecher JA Gross J Johnston K Madden, et al. 2000 Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function Nature 408 57 63 11081504 10.1038/35040504 1:CAS:528:DC%2BD3cXotVaksrw%3D
9. J Li W Shen K Kong Z Liu 2006 Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis Scand J Immunol 64 515 522 17032244 10.1111/j.1365-3083.2006.01795.x 1:CAS:528: DC%2BD28Xht1ahtLnJ (Pubitemid 44536336)
10. B Oppmann R Lesley B Blom JC Timans Y Xu B Hunte F Vega N Yu, et al. 2000 Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 13 715 725 11114383 10.1016/S1074-7613(00)00070-4 1:CAS:528:DC%2BD3cXovV2ht7c%3D
11. C Parham M Chirica J Timans E Vaisberg M Travis J Cheung S Pflanz R Zhang, et al. 2002 A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R J Immunol 168 5699 5708 12023369 1:CAS:528:DC%2BD38XktFCrtrw%3D (Pubitemid 34556153)
12. CL Leonardi AB Kimball KA Papp N Yeilding C Guzzo Y Wang S Li LT Dooley, et al. 2008 Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) Lancet 371 1665 1674 18486739 10.1016/S0140-6736(08)60725-4 1:CAS:528:DC%2BD1cXlvFymt7o%3D (Pubitemid 351671883)
13. C Jandus G Bioley JP Rivals J Dudler D Speiser P Romero 2008 Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides Arthritis Rheum 58 2307 2317 18668556 10.1002/art.23655
14. PI Sidiropoulos G Hatemi IH Song J Avouac E Collantes V Hamuryudan M Herold TK Kvien, et al. 2008 Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists Rheumatology (Oxford) 47 355 361 10.1093/rheumatology/kem348 1:STN:280:DC%2BD1c7hvVSnuw%3D%3D (Pubitemid 351267206)
15. M Dougados S van der Linden R Juhlin B Huitfeldt B Amor A Calin A Cats B Dijkmans, et al. 1991 The European Spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy Arthritis Rheum 34 1218 1227 1930310 10.1002/art.1780341003 1:STN:280:DyaK38%2FivFSqsA%3D%3D
16. KB Madsen AG Jurik 2010 MRI grading method for active and chronic spinal changes in spondyloarthritis Clin Radiol 65 6 14 20103415 10.1016/j.crad.2009. 08.009 1:STN:280:DC%2BC3c%2FmtVegsg%3D%3D
17. KB Madsen AG Jurik 2010 Magnetic resonance imaging grading system for active and chronic spondylarthritis changes in the sacroiliac joint Arthritis Care Res (Hoboken) 62 11 18 10.1002/acr.20008
18. AV Rachitskaya AM Hansen R Horai Z Li R Villasmil D Luger RB Nussenblatt RR Caspi 2008 Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion J Immunol 180 5167 5171 18390697 1:CAS:528: DC%2BD1cXkt1ars7o%3D
19. DJ Cua J Sherlock Y Chen CA Murphy B Joyce B Seymour L Lucian W To, et al. 2003 Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 421 744 748 12610626 10.1038/nature01355 1:CAS:528:DC%2BD3sXhsV2rsbs%3D (Pubitemid 36227625)
20. J Pesce M Kaviratne TR Ramalingam RW Thompson JF Urban Jr AW Cheever DA Young M Collins, et al. 2006 The IL-21 receptor augments Th2 effector function and alternative macrophage activation J Clin Invest 116 2044 2055 16778988 10.1172/JCI27727 1:CAS:528:DC%2BD28XmvV2lu70%3D (Pubitemid 44033328)
21. M Rudwaleit S Schwarzlose ES Hilgert J Listing J Braun J Sieper 2008 MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis Ann Rheum Dis 67 1276 1281 18006539 10.1136/ard.2007.073098 1:STN:280:DC%2BD1crhtlWjtA%3D%3D
22. KB S-CB Madsen AG Jurik 2010 Prognostic significance of MR changes of the sacroiliac joints in spondyloarthritis. A follow-up study J Rheumatol 37 1718 1727 20516024 10.3899/jrheum.091155
23. L Melis B Vandooren E Kruithof P Jacques M De Vos H Mielants G Verbruggen F Keyser, et al. 2009 Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis Ann Rheum Dis 69 618 623 19196728 10.1136/ard.2009.107649
24. X Wang Z Lin Q Wei Y Jiang J Gu 2009 Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis Rheumatol Int 29 1343 1347 19247658 10.1007/s00296-009-0883-x 1:CAS:528:DC%2BD1MXhtVSit7rM